-
Targeted re-sequencing of multi-region sampled tumors in PDAC
Study
EGAS50000000239
-
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple negative breast cancer: phase 2 adaptive BELLINI trial. WES
Study
EGAS50000000568
-
Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study
Dac
EGAC50000000753
-
Cell-Free DNA Fragmentation Distinguish Immunotherapy Responders from Non- Responders in Head and Neck Cancer: A Multi-Institute Prospective Study
Study
EGAS50000001286
-
Epigenetic characterization of glioblastoma stem cells
Study
EGAS50000001804
-
Single-cell and spatial transcriptomic profiling of peritoneal metastasis of gastric cancer
Study
EGAS50000001875
-
Peritoneal Metastasis of Gastric Cancer Data Access Committee
Dac
EGAC50000001025
-
Circulating Cell-free DNA Whole Genome Sequencing from Head and Neck Cancer Patients
Dataset
EGAD50000001828
-
Raw transcriptomic sequencing data from peritoneal metastasis of gastric cancer
Dataset
EGAD50000002714
-
Rituximab-treated lymphoma patients show correlated deficiency in serological and T cell Spike-specific response after SARS-CoV-2 vaccination: insights from the CORSA Study.
Study
EGAS50000001205